1,1'-Carbonyldiimidazole → HCID 118023243, compound
Reaction equation
[CH:1]1([C:7]2[S:23][C:10]3[N:11]=[C:12]([CH3:22])[N:13]=[C:14]([CH2:15][NH:16][C:17]([CH3:21])([CH3:20])[CH2:18][OH:19])[C:9]=3[CH:8]=2)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.C1N=CN([C:29](N2C=NC=C2)=[O:30])C=1>C(Cl)Cl>[CH:1]1([C:7]2[S:23][C:10]3[N:11]=[C:12]([CH3:22])[N:13]=[C:14]([CH2:15][N:16]4[C:17]([CH3:20])([CH3:21])[CH2:18][O:19][C:29]4=[O:30])[C:9]=3[CH:8]=2)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a mixture of 2-{[(6-cyclohexyl-2-methylthieno[2,3-d]pyrimidin-4-yl)methyl]amino}-2-methylpropan-1-ol (55 mg) and DCM was added CDI (40 mg), followed by stirring at room temperature for 6 hours. The reaction mixture was concentrated under reduced pressure. The residue was purified by silica gel column (hexane/EtOAc) to obtain 3-[(6-cyclohexyl-2-methylthieno[2,3-d]pyrimidin-4-yl)methyl]-4,4-dimethyl-1,3-oxazolidin-2-one (54 mg).
Workup
- concentrationThe reaction mixture was concentrated under reduced pressure
- customThe residue was purified by silica gel column (hexane/EtOAc)
Sources & evidence
- ORD record
- ord-b1b1f9072b974a7d838cb20809648a5c
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09051339B2
Reaction notes
Loading…